Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals

October 27, 2021 updated by: University Hospital, Basel, Switzerland

Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services

Heads of all psychosomatic, psychiatric and psychological consultation and liaison (C&L) services in acute care hospitals across all participating countries will be contacted and asked to participate in this international cross-sectional online survey. The survey consists of questions about care structures and their utilisation that psychosomatic, psychiatric and psychological C&L services have established in acute hospitals in the context of the COVID 19 pandemic.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background:

The COVID-19 pandemic raised new challenges in supporting patients, relatives and staff for psychosomatic, psychiatric and psychological C&L services in general hospitals worldwide. It is intended to build upon the experience gained so far in order to be well prepared for the future.

Objectives:

The aims of this international online survey are

  1. To summarize the efforts made in psychosocial care in the context of the COVID-19 pandemic.
  2. To assess the experiences made with the established services so far.
  3. To assess the need for networking, cooperation and support.
  4. Improvement of psychosocial care in acute hospitals in the context of pandemics.

Study Design:

This health services research project will be carried out as an observational study in the form of an international cross-sectional online survey.

There will be one survey time point. Study reporting will follow the STROBE Statement (Strengthening the Reporting of Observational Studies in Epidemiology).

Ethic approval:

In all participating countries the respective ethics committees were informed about the survey and it was checked with them, how far and what kind of country-specific vote of an ethics committee was necessary. Written statements, declarations or votes were obtained from all participating countries.

Setting:

The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries are contacted and asked to participate. Contact is made via the respective national professional societies and relevant working and interest groups.

Participants This study is an international online survey with psychosomatic, psychiatric and psychological C&L services from 14 European countries (Austria, Belgium, Finland, Germany, France, Greece, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom) as well as parts of Canada (Quebec and Ontario region) and Iran participating.

Country specific regions:

The national coordinators of the participating country provided lists of specific regions for their respective country following the NUTS logic (Nomenclature of Territorial Units for Statistics; https://en.wikipedia.org/wiki/Nomenclature_of_Territorial_Units_for_Statistics), preferably a NUTS level that leads to 5 - 20 NUTS for each country.

Online survey questionnaire:

Self-developed questionnaire based on relevant literature, own experience and consultation with participating professional societies. The survey contains 25 questions on structural and process variables regarding characterization of the participating C&L services, involvement of the respective hospitals in the physical care of COVID-19 patients, structures / organization of psychosocial care for COVID-19 patients in the participating hospitals, specific psychosocial support for patients, relatives and staff established in the participating hospital in the context of COVID-19, communication - How the different target groups were informed about the COVID-19 related psychosocial support services and offers, burden of the COVID-19 pandemic on the psychosocial C&L teams, needs and wishes for the future.

The study questionnaire was translated by a professional company from German into English, French and Italian. Language harmonization and cultural adaptation followed a modified committee-based approach informed by the European Social Survey (ESS) Round 9 Translation Guidelines. Participants are free to choose the language version to be worked on.

Study Type

Observational

Enrollment (Actual)

230

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Austria
    • Steiermark
      • Graz, Steiermark, Austria, 8036
        • Medical University of Graz, University Hospital Graz
  • Belgium
      • Ghent, Belgium
        • Ghent University Hospital, Department of Psychiatry
  • Canada
      • Montreal, Canada
        • University of Montreal, Department of Psychosomatic Medicine
      • Toronto, Canada
        • TorontoSinai Health, University of Toronto, Department of Psychiatry
  • Finland
      • Oulu, Finland, 90220
        • Oulu University Hospital and University of Oulu
  • France
      • Paris, France
        • Université de Paris, Service de Psychiatrie de l'adulte
  • Germany
    • Bayern
      • Nürnberg, Bayern, Germany, 90419
        • Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy
    • Nordrhein-Westfalen
      • Köln, Nordrhein-Westfalen, Germany, 50937
        • University Hospital Cologne, Department of Psychosomatics and Psychotherapy
  • Greece
      • Thessaloniki, Greece
        • Aristotle University Thessaloniki
  • Iran, Islamic Republic of
      • Tehran, Iran, Islamic Republic of
        • University of Medical Sciences, Department of Psychiatry
  • Ireland
      • Dublin, Ireland
        • University College Dublin
  • Italy
      • Bologna, Italy, 40123
        • Bologna University
      • Modena, Italy, 411274
        • University of Modena & Reggio Emilia
  • Norway
      • Oslo, Norway
        • Oslo University Hospital
  • Poland
      • Wroclaw, Poland
        • Wroclaw Medical University
  • Portugal
      • Lisboa, Portugal
        • Hospital de Santa Maria
      • Lisboa, Portugal
        • Universidade Católica Portuguesa Lisboa
  • Spain
      • Barcelona, Spain
        • Barcelona University
  • Switzerland
      • Basel, Switzerland, 4002
        • University of Basel, Department of Psychiatry (UPK)
    • Basel-City
      • Basel, Basel-City, Switzerland, 4031
        • University Hospital Basel, Department of Psychosomatic Medicine
  • United Kingdom
      • Exeter, United Kingdom
        • University of Exeter
      • York, United Kingdom
        • University of York

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries will be contacted and asked to participate. Contact will be made via the respective national professional societies and relevant working and interest groups

Description

Inclusion Criteria:

  • heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Structural and process quality of COVID-19 related psychosocial C&L services
Time Frame: 6 months

Data basis for improving quality of COVID-19 related psychosocial C&L services:

  1. characterization of participating C&L services
  2. involvement of respective hospitals in the physical care of COVID-19 patients
  3. structures/ organization of psychosocial care for COVID-19 patients in participating hospitals

  4. specific psychosocial support established in participating hospitals in context of COVID-19 for

    1. patients
    2. relatives
    3. staff
  5. communication strategies - How the different target groups were informed about COVID-19 related psychosocial support services and offers
  6. burden of COVID-19 pandemic on psychosocial C&L teams

  7. needs and wishes of the participating psychosocial C&L services

    1. for support or exchange of experience regarding psychosocial care in the COVID 19 context
    2. for changes / improvements considered essential for the future with regard to psychosocial care services in the participating hospitals in the COVID-19 context
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Basel, Switzerland

Investigators

  • Principal Investigator: Rainer Schaefert, Prof. Dr. med., University Hospital, Basel, Switzerland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 8, 2020

Primary Completion (Actual)

October 3, 2021

Study Completion (Actual)

October 3, 2021

Study Registration Dates

First Submitted

February 11, 2021

First Submitted That Met QC Criteria

February 11, 2021

First Posted (Actual)

February 15, 2021

Study Record Updates

Last Update Posted (Actual)

October 28, 2021

Last Update Submitted That Met QC Criteria

October 27, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Req-2020-00861; th21Schaefert

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid-19

Clinical Trials on Online survey questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe